Did you know ASTCT webinars are free to register for? We have a full calendar of upcoming webinars related to #HCT, #CART, #pharmacy, #Tandem25 sessions and more. View all webinars and register to attend one this month: www.astct.org/Meetings/Mee... #OncSky #HemeSky #MedSky
August 25, 2025 at 9:56 PM
Everybody can reply
1 likes
Ide-Cel Displays Potential in Myeloma After Suboptimal Response to Frontline ASCT and Maintenance @pennmedicine.bsky.social @astct.bsky.social #Tandem25
#MultipleMyeloma #MMSM
www.onclive.com/view/ide-cel...
#MultipleMyeloma #MMSM
www.onclive.com/view/ide-cel...
Ide-Cel Displays Potential in Myeloma After Suboptimal Response to Frontline ASCT and Maintenance
Alfred L. Garfall, MD, discusses the role of ide-cel in patients with multiple myeloma following suboptimal responses to upfront auto-HCT.
www.onclive.com
April 7, 2025 at 5:37 PM
Everybody can reply
1 reposts
Check out incredible advances from MSK physicians and scientists that were presented at #Tandem25! Congrats to Sergio Giralt on giving the honorary Mortimer M. Bortin Lecture about the rapid advances that have changed transplant practice in the past three decades. @drmiguelperales.bsky.social
Physicians and scientists from MSK presented advances in transplantation and cellular therapies at the Tandem Meetings. Presentations highlighted new ways to improve outcomes for people with #bloodcancers. Read the recap ⬇️ #medsky #cansky
MSK Experts Present Advances in Bone Marrow Transplant and Cellular Therapy Research at Prestigious Conference
Physicians and scientists from MSK presented advances in transplantation and cellular therapies at the Tandem Meetings, a joint event hosted by the American Society for Transplantation and Cellular Th...
www.mskcc.org
February 27, 2025 at 3:29 PM
Everybody can reply
2 reposts
2 likes
Great to see @mskcancercenter.bsky.social team shine at #tandem25 meeting & honored to work with such a talented group of colleagues
Physicians and scientists from MSK presented advances in transplantation and cellular therapies at the Tandem Meetings. Presentations highlighted new ways to improve outcomes for people with #bloodcancers. Read the recap ⬇️ #medsky #cansky
MSK Experts Present Advances in Bone Marrow Transplant and Cellular Therapy Research at Prestigious Conference
Physicians and scientists from MSK presented advances in transplantation and cellular therapies at the Tandem Meetings, a joint event hosted by the American Society for Transplantation and Cellular Th...
www.mskcc.org
February 26, 2025 at 10:53 PM
Everybody can reply
4 likes
Orca-Q Delivers Early Evidence of GVHD Risk Mitigation in Hematologic Malignancies @cityofhope.bsky.social #Tandem25 #oncology www.onclive.com/view/orca-q-...
Orca-Q Delivers Early Evidence of GVHD Risk Mitigation in Hematologic Malignancies
Amandeep Salhotra, MD, discusses data that have demonstrated the anti-GVHD activity of post-transplant Orca-Q in patients with hematologic malignancies.
www.onclive.com
February 26, 2025 at 2:45 PM
Everybody can reply
🧬 #Tandem25 Recap: This session explored the promise of next-generation sequencing in TID, while also addressing key challenges.
Learn more: ow.ly/MBjM50V6jnE
Learn more: ow.ly/MBjM50V6jnE
February 25, 2025 at 5:59 PM
Everybody can reply
1 reposts
2 likes
Last week, Roswell Park experts gathered with top specialists at #TANDEM25 for Transplantation and Cellular Therapy, hosted by @astct.bsky.social and @cibmtr.bsky.social.
We’re so proud of our team for sharing their expertise and innovations on this big stage!
We’re so proud of our team for sharing their expertise and innovations on this big stage!
February 18, 2025 at 6:30 PM
Everybody can reply
3 likes
Today is the 3nd annual #GVHDday. This Day was established to symbolize an enduring solidarity with the GVHD community.
Help amplify the voices affected by GVHD & share this message.
🌐 Visit GVHDalliance.org to get involved.
#GVHDconnect4hope #GVHDAlliance #aGVHD #BMT #HSCT #HCT #bmtsm #Tandem25
Help amplify the voices affected by GVHD & share this message.
🌐 Visit GVHDalliance.org to get involved.
#GVHDconnect4hope #GVHDAlliance #aGVHD #BMT #HSCT #HCT #bmtsm #Tandem25
February 17, 2025 at 10:33 PM
Everybody can reply
What a wonderful #Tandem25! As always, the best of the conference is in the conversations and brainstorming between and outside the sessions; so wonderful to reconnect with mentors, friends, acquaintances from around the world in one of the most beautiful places I have ever visited.
February 17, 2025 at 2:30 PM
Everybody can reply
1 likes
Great way to end #tandem25 in Hawaii by hiking Koko Crater with Boston colleagues.
February 17, 2025 at 12:24 AM
Everybody can reply
9 likes
Ide-Cel Boosts Response in Myeloma With < CR After Upfront Auto-HCT and Lenalidomide Maintenance @algarfall.bsky.social @pennmedicine.bsky.social @penncancer.bsky.social @astct.bsky.social #TANDEM25 #hematology
www.onclive.com/view/ide-cel...
www.onclive.com/view/ide-cel...
Ide-Cel Boosts Response in Myeloma With < CR After Upfront Auto-HCT and Lenalidomide Maintenance
Ide-cel proved feasible and effective in boosting response in patients with myeloma with suboptimal response to standard frontline therapy.
www.onclive.com
February 16, 2025 at 6:16 PM
Everybody can reply
1 likes
Non-Myeloablative HSCT Regimen Shows Potential for Immune Tolerance in Haploidentical Living Donor Combined Kidney/Hematopoietic Transplant #TANDEM25 www.onclive.com/view/non-mye...
Non-Myeloablative HSCT Regimen Shows Potential for Immune Tolerance in Haploidentical Living Donor Combined Kidney/Hematopoietic Transplant
Non-myeloablative HSCT with TLI/TBI/ATG conditioning was safe and active in eliciting immune quiescence and tolerance.
www.onclive.com
February 16, 2025 at 6:05 PM
Everybody can reply
FOXP3/Helios Expression in CD4+ Tcons Correlates With T-Cell Activation After Orca-T in Hematologic Malignancies @astct.bsky.social @stanfordmedicine.bsky.social #TANDEM25 #oncology www.onclive.com/view/foxp3-h...
FOXP3/Helios Expression in CD4+ Tcons Correlates With T-Cell Activation After Orca-T in Hematologic Malignancies
CD4-, FOXP3-, and Helios-positive conventional T cells were increased in patients receiving Orca-T vs peripheral blood stem cell grafts.
www.onclive.com
February 16, 2025 at 5:04 PM
Everybody can reply
Another great Tandem meeting in the books. Congratulations to the organizing committee chaired by Melody Smith & Marie Bleakley - see everyone in Salt Lake City next year #tandem25
February 16, 2025 at 3:34 AM
Everybody can reply
13 likes
Also relevant in non-malignant conditions-- at Q&A session re: Lenmeldy for MLD, average time to approval is 6-12 months, which means 6-12 months of neurodegeneration before cure.
"This is not going to be as effective as it's supposed to be if we don't have early diagnosis and procedures" #Tandem25
"This is not going to be as effective as it's supposed to be if we don't have early diagnosis and procedures" #Tandem25
February 16, 2025 at 12:35 AM
Everybody can reply
#tandem25 #bmtsm: Amazingly, the @cibmtr.bsky.social Immunobiology working committee meeting, which used to be a 4-hour marathon, was finished today in just over an hour. Have we answered all the questions, or is just another sign that HLA is no longer king in the PTCy era?
February 16, 2025 at 12:30 AM
Everybody can reply
4 likes
Fascinating talk on how to predict & optimize cell/gene therapy capacity/throughput from Julie Porter @danafarber.bsky.social.
In addition to all the plenary session payers worried by #celltx #genetx costs-- how do hospitals balance urgency & risk that if they treat they won't get paid? #tandem25
In addition to all the plenary session payers worried by #celltx #genetx costs-- how do hospitals balance urgency & risk that if they treat they won't get paid? #tandem25
February 16, 2025 at 12:23 AM
Everybody can reply
1 reposts
2 likes
#tandem25 #bmtsm Mehta: in haploHCT for leukemia/MDS variables that favorably impact outcome included B-leader matching, DRB1-mismatching, DQB1-matching, and DPB1 non-permissive mismatching. When you have these data available, there is an online calculator to help with donor selection.
February 15, 2025 at 11:52 PM
Everybody can reply
1 reposts
2 likes
February 15, 2025 at 11:33 PM
Everybody can reply
2 reposts
5 likes
